Murthy Sudish C, Blackstone Eugene H, Gildea Thomas R, Gonzalez-Stawinski Gonzalo V, Feng Jing, Budev Marie, Mason David P, Pettersson Gösta B, Mehta Atul C
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Ann Thorac Surg. 2007 Aug;84(2):401-9, 409.e1-4. doi: 10.1016/j.athoracsur.2007.05.018.
Because improper airway healing continues as a source of morbidity after lung transplantation, we determined prevalence and risk factors for anastomotic complications and examined their impact on survival.
From January 1997 to January 2004, 272 patients undergoing pulmonary transplantation were studied for anastomotic airway complications. Complications were categorized as necrosis or obstruction and treatment as none, endoscopic (stenting, bronchoplasty, ablation), or open repair. Survival impact was assessed by follow-up (mean, 3.0 +/- 2.2 years) using competing-risks nonproportional hazards methodology in the context of repeated events.
By 24 months, 94 anastomotic airway complications (26 necrotic, 67 obstructive, 1 torsion) had developed in 48 patients (18%), and 23 (8.5% overall; 48% of affected patients) underwent intervention. Risk of necrotic complications preceded obstruction. Risk factors were telescoping anastomosis (p < 0.0001), more recent transplant (p < 0.0001), donor-recipient size mismatch (p = 0.008), and previously treated anastomotic airway complication (p < 0.0001). Seventy-eight interventions were performed for 60 of the 94 complications. Compared with patients experiencing no anastomotic airway complications, those with treated complications had equivalent early survival (82% versus 80% at 12 months, p = 0.9) but worse late survival (60% versus 27% at 48 months, p = 0.03), and those with untreated complications had worse early survival (82% versus 62% at 12 months, p = 0.004) but equivalent late survival (p = 0.4).
Anastomotic airway complications occur in about one fifth of patients after lung transplantation and are formidable and persistent problems. Early complications are necrosis, followed by obstruction. Few risk factors are modifiable. Because these complications importantly affect survival, improving efficacy of intervention strategies should improve outcome.
由于肺移植后气道愈合不当仍是发病的一个原因,我们确定了吻合口并发症的发生率和危险因素,并研究了它们对生存率的影响。
从1997年1月至2004年1月,对272例接受肺移植的患者进行吻合口气道并发症研究。并发症分为坏死或梗阻,治疗方法分为不治疗、内镜治疗(支架置入、支气管成形术、消融)或开放修复。在重复事件的背景下,采用竞争风险非比例风险方法通过随访(平均3.0±2.2年)评估对生存率的影响。
到24个月时,48例患者(18%)出现了94例吻合口气道并发症(26例坏死、67例梗阻、1例扭转),23例(总体8.5%;受影响患者的48%)接受了干预。坏死性并发症的风险先于梗阻。危险因素包括套叠式吻合(p<0.0001)、近期移植(p<0.0001)、供受者大小不匹配(p=0.008)以及先前治疗过的吻合口气道并发症(p<0.0001)。对94例并发症中的60例进行了78次干预。与未发生吻合口气道并发症的患者相比,发生并发症并接受治疗的患者早期生存率相当(12个月时分别为82%和80%,p=0.9),但晚期生存率较差(48个月时分别为60%和27%,p=0.03),而发生并发症未接受治疗的患者早期生存率较差(12个月时分别为82%和62%,p=0.004),但晚期生存率相当(p=0.4)。
肺移植后约五分之一的患者会发生吻合口气道并发症,这是严重且持续存在的问题。早期并发症是坏死,其次是梗阻。几乎没有可改变的危险因素。由于这些并发症对生存率有重要影响,提高干预策略的疗效应能改善预后。